List of Excipients in API buprenorphine buccal
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing buprenorphine buccal
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 | .ALPHA.-TOCOPHEROL ACETATE |
Alvogen Inc | buprenorphine buccal | 47781-471 | ANHYDROUS CITRIC ACID |
Alvogen Inc | buprenorphine buccal | 47781-471 | CARBOXYMETHYLCELLULOSE SODIUM |
Alvogen Inc | buprenorphine buccal | 47781-471 | FERRIC OXIDE YELLOW |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for buprenorphine buccal
Excipient focus: .ALPHA.-TOCOPHEROL ACETATE
buprenorphine buccal drug variants containing .ALPHA.-TOCOPHEROL ACETATE
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing .ALPHA.-TOCOPHEROL ACETATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
buprenorphine buccal drug variants containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
buprenorphine buccal drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
buprenorphine buccal drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
buprenorphine buccal drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
buprenorphine buccal drug variants containing HYDROXYETHYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing HYDROXYETHYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
buprenorphine buccal drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
buprenorphine buccal drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PEPPERMINT OIL
buprenorphine buccal drug variants containing PEPPERMINT OIL
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing PEPPERMINT OIL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYCARBOPHIL
buprenorphine buccal drug variants containing POLYCARBOPHIL
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing POLYCARBOPHIL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
buprenorphine buccal drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
buprenorphine buccal drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SACCHARIN SODIUM
buprenorphine buccal drug variants containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing SACCHARIN SODIUM
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
buprenorphine buccal drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
buprenorphine buccal drug variants containing SODIUM BENZOATE
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing SODIUM BENZOATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
buprenorphine buccal drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
buprenorphine buccal drug variants containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
buprenorphine buccal drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: WATER
buprenorphine buccal drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Alvogen Inc | buprenorphine buccal | 47781-471 |
>Company | >Ingredient | >NDC |
buprenorphine buccal drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.